Thursday, August 5, 2021

Mesothelioma asbestos cure hope by Novocure NovoTTF-100L Now Offered to Mesothelioma Patients

Mesothelioma Cancer Medicine NovoTT-100-L
Novocure announced that the United States Food and Drug Administration (FDA) had approved the NovoTTF-100L System for treating pleural mesothelioma. Almost exactly four months later, patients with this cancer can now access the treatment. And one patient...

Active agent from the Caribbean sea cucumber could improve treatment for malignant pleural mesothelioma

Mesothelioma Cure Caribbean Sea Cucumber
Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma. For the first time in the world, they were able to show in a preclinical study, both in the...

What’s New in Malignant Mesothelioma Research?

There's always research going on in the area of mesothelioma. Scientists are looking for better ways to prevent, diagnose, and treat mesothelioma, as well as find it before it causes problems. Because mesothelioma is rare, it's been hard to...

Clinical Trial Offering Personalized Immunotherapy for Mesothelioma

Patients with mesothelioma are now eligible for a multicancer clinical trial studying the effectiveness of personalized immunotherapy at the University of California, San Diego Medical Center. The phase I clinical trial involves a combination of Keytruda (pembrolizumab), a proven immunotherapy drug, and an...

Mesothelioma Researchers: Immunotherapy Drug Ofev Doesn’t Work

Mesothelioma Immunotherapy
The results of a recent Phase 3 clinical trial have led to a disappointing setback for the mesotheliomacommunity: a highly-touted immunotherapy drug has failed to stop the progression of the disease. Researchers involved in the LUME-Meso study, which combined Ofev (nintedanib) with...

Recent Posts